ZYDUSLIFE Zydus Lifesciences Ltd Disruption of operations due to natural disasters, accidents, or other events Announcement 2023 - Product Launches Zydus Lifesciences Ltd received tentative approval from the USFDA for Palbociclib Tablets, 75 mg, 100 mg, and 125 mg..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd